EUVIMEDEUVIMED entdecken
Crossref

Incidence of cutaneous malignancy following the concomitant use of ciclosporin and narrowband ultraviolet B phototherapy in patients with vitiligo

Jae Joon Jeon iD, You Hyun Kim iD, Hyunsoo Son iD, Ju Yeong Lee iD, Min Chul Ha iD, Seung-Won Jung iD, Solam Lee iD

Clinical and Experimental Dermatology · 2025

DOI: 10.1093/ced/llaf428 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Experimental Dermatology, 2025. Verfasst von Jae Joon Jeon und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Yonsei University Wonju College of Medicine, Wonju, Republic of Korea. Hauptthemen laut MEDLINE: Vitiligo, Ultraviolet Therapy, Cyclosporine, Skin Neoplasms. Die Arbeit nennt 8 Literaturangaben. Gefördert von: Korea Health Technology Research, Korea Health Industry Development Institute, Ministry of Health and Welfare.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This nationwide population-based cohort study investigates the incidence of cutaneous malignancies associated with the concomitant treatment of ciclosporin and narrowband ultraviolet B (NBUVB) phototherapy in patients with vitiligo, using the Korean National Health Insurance Service database. Concomitant ciclosporin and NBUVB phototherapy may not significantly increase the incidence of cutaneous malignancies. Given the chronic autoimmune nature of vitiligo and its economic impact, these findings provide novel insights into the potential safety of these combination regimens.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VitiligoUltraviolet TherapyCyclosporineSkin NeoplasmsDermatologic AgentsImmunosuppressive AgentsHumansMaleFemaleAdultIncidenceMiddle AgedRepublic of KoreaYoung AdultAdolescentAgedChildCombined Modality TherapyCohort Studies

Substanzen

CyclosporineDermatologic AgentsImmunosuppressive Agents

Autor:innen und Institutionen

  • Department of Dermatology, Yonsei University Wonju College of Medicine, Wonju, Republic of Korea.
  • Institute of Evidence Based Medicine, Yonsei University Wonju College of Medicine, Wonju, Republic of Korea.
  • Department of Bioengineering, College of Engineering, University of Washington, Seattle, WA, USA.
  • Washington National Primate Research Center, Seattle, Washington, USA.
  • Fred Hutchinson Cancer Center, Seattle, Washington, USA.
  • Galleria Dermatology, Seoul, Republic of Korea.

ORCID-Profile: Jae Joon Jeon, You Hyun Kim, Hyunsoo Son, Ju Yeong Lee, Min Chul Ha, Seung-Won Jung, Solam Lee

Förderung

  • Korea Health Technology Research
  • Korea Health Industry Development Institute
  • Ministry of Health and Welfare

Zitieren

APA

Jeon, J. J., Kim, Y. H., Son, H., Lee, J. Y., Ha, M. C., Jung, S. W., & Lee, S. (2025). Incidence of cutaneous malignancy following the concomitant use of ciclosporin and narrowband ultraviolet B phototherapy in patients with vitiligo. Clinical and Experimental Dermatology. https://doi.org/10.1093/ced/llaf428

Vancouver

Jeon JJ, Kim YH, Son H, Lee JY, Ha MC, Jung SW, et al. Incidence of cutaneous malignancy following the concomitant use of ciclosporin and narrowband ultraviolet B phototherapy in patients with vitiligo. Clinical and Experimental Dermatology. 2025. doi:10.1093/ced/llaf428

BibTeX
@article{Jeon2025,
  author = {Jeon, Jae Joon and Kim, You Hyun and Son, Hyunsoo and Lee, Ju Yeong and Ha, Min Chul and Jung, Seung-Won and Lee, Solam},
  title = {Incidence of cutaneous malignancy following the concomitant use of ciclosporin and narrowband ultraviolet B phototherapy in patients with vitiligo},
  journal = {Clinical and Experimental Dermatology},
  year = {2025},
  doi = {10.1093/ced/llaf428}
}
Kostenlos starten →